戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lyzed by sphingomyelinases into ceramide and phosphorylcholine.
2 -choline-labelled cell walls was shown to be phosphorylcholine.
3 lyzed by sphingomyelinases into ceramide and phosphorylcholine.
4 A fraction of these antibodies bound to free phosphorylcholine.
5 m infected rats and shown to be specific for phosphorylcholine.
6 5'-thymidine monophosphate and p-nitrophenyl phosphorylcholine.
7 acterial cell wall polysaccharide component, phosphorylcholine.
8  encoding for antibodies targeting bacterial phosphorylcholine.
9 dum lipid showed that the target of M131 was phosphorylcholine.
10 ecognition of ES-62 by target cells, because phosphorylcholine, a common pathogen-associated molecula
11 ice, anti-phosphatidylcholine Abs, like anti-phosphorylcholine Abs, contain few N-additions, and have
12 is and A. actinomycetemcomitans include anti-phosphorylcholine (alpha-PC) and beta2-glycoprotein-1-de
13 age cytokine responses, a sulfone-containing phosphorylcholine analogue (11a) was selected for testin
14 ) catalyzes the cleavage of sphingomyelin to phosphorylcholine and ceramide, an essential step in the
15 nzyme that hydrolyzes sphingomyelin (SPM) to phosphorylcholine and ceramide.
16  is first used to hydrolyze sphingomyelin to phosphorylcholine and ceramide.
17 o their equivalent 1H NMR spectra, e.g., for phosphorylcholine and phosphorylethanolamine.
18 e phospholipase A(2) inhibitor oleyloxyethyl phosphorylcholine and the CYP450 inhibitor ketoconazole.
19 ned that recognize simultaneously the hapten phosphorylcholine and the self antigen double-stranded D
20  phosphatase then generates choline from the phosphorylcholine, and the newly formed choline is then
21 ytidine diphosphate-choline as the donor for phosphorylcholine, AnkX catalyzes the transfer of phosph
22                                  Abs against phosphorylcholine (anti-PC) and Abs against malondialdeh
23 ss contain higher concentrations of IgG anti-phosphorylcholine (anti-PC) than sera from healthy subje
24 ollowed using the chromophoric p-nitrophenyl-phosphorylcholine as a model substrate.
25 romol/min.mg toward 1-palmitoyl-sn-glycero-3-phosphorylcholine at pH 8.0 and 40 degrees C, correspond
26                                       The Au-phosphorylcholine (Au-PC) probes exhibit 'super-stealth'
27 entity with antibodies from the classic anti-phosphorylcholine B-cell clone, T15, which protect again
28                  Therefore, the potential of phosphorylcholine-based vaccination strategies as a nove
29                                              Phosphorylcholine-based zotarolimus-eluting stents had l
30 fore, our findings do not support a role for phosphorylcholine-bearing antigens in immune defense aga
31                      Antibodies specific for phosphorylcholine-bearing proteins of L1 larvae first ap
32 infection with T. spiralis were specific for phosphorylcholine-bearing proteins.
33 n are based on poly(2-(methacryloyloxy)ethyl phosphorylcholine-block-2-(diisopropylamino)ethyl methac
34 em is based on poly[2-(methacryloyloxy)ethyl phosphorylcholine]-block-[2-(diisopropylamino)ethyl meth
35 d the serum levels of NAbs against bacterial phosphorylcholine but not oxidized low-density lipoprote
36 ce mounted robust antibody responses against phosphorylcholine, but not protein, determinants compare
37 g, and that pchP and other genes involved in phosphorylcholine catabolism are necessary to stimulate
38 pendent manner, and binding was inhibited by phosphorylcholine (ChoP) and choline.
39 the additional LPS phase variable structures phosphorylcholine (ChoP) and sialic acid.
40 tal choline into lipopolysaccharide (LPS) as phosphorylcholine (ChoP) as well as the phase variation
41       Incorporated choline is in the form of phosphorylcholine (ChoP) based on the reactivity with th
42                                              Phosphorylcholine (ChoP) can be found in all life forms.
43                 The phase-variable structure phosphorylcholine (ChoP) confers susceptibility to human
44 dergoes phase variation in expression of the phosphorylcholine (ChoP) epitope, a structure present on
45       In addition, H. somni cells expressing phosphorylcholine (ChoP) induced aggregation, while ChoP
46                                              Phosphorylcholine (ChoP) is a common surface feature of
47                                              Phosphorylcholine (ChoP) is a component of the teichoic
48                                              Phosphorylcholine (ChoP) is a potential candidate for a
49                                              Phosphorylcholine (ChoP) is an antigenic component on th
50  that the LOS from H. haemolyticus contained phosphorylcholine (ChoP) less frequently than the LOS fr
51 irway infection models, we demonstrated that phosphorylcholine (ChoP) moieties that are shared by PAF
52 tures found within NTHi LOS suggested that a phosphorylcholine (ChoP) moiety was involved in adherenc
53                                 CRP binds to phosphorylcholine (ChoP), a constituent of eukaryotic me
54 Haemophilus influenzae, express cell-surface phosphorylcholine (ChoP), a ligand for the receptor for
55 in both licl, required for the expression of phosphorylcholine (ChoP), and lic2, a putative galactosy
56 c-1, which is required for the expression of phosphorylcholine (ChoP), is the best characterized and
57 ct express an unusual prokaryotic structure, phosphorylcholine (ChoP), on their cell surface.
58               Here, we demonstrated that the phosphorylcholine (ChoP)-containing outer membrane prote
59 ental sources onto its lipopolysaccharide as phosphorylcholine (ChoP).
60                         Thus, PAFr shepherds phosphorylcholine-containing bacterial components such a
61 sly demonstrated that one such molecule, the phosphorylcholine-containing glycoprotein ES-62, acts to
62            Here we demonstrate that ES-62, a phosphorylcholine-containing glycoprotein released by th
63 cribed a filarial nematode-derived, secreted phosphorylcholine-containing glycoprotein, ES-62, with i
64 d not react with red blood cells, which have phosphorylcholine-containing lipids in their exterior me
65                                              Phosphorylcholine-containing secreted products (phosphor
66  enzyme activity are positively regulated by phosphorylcholine degradation products, including glycin
67 for the capsular polysaccharide (PPS14), the phosphorylcholine determinant of the cell wall C-polysac
68 ntigen-binding activities to haptens such as phosphorylcholine, dextrans, fructofuranans, or dinitrop
69 SNPE) headgroup, while the other contained a phosphorylcholine (DiC(6)SNPC) headgroup.
70 is study, we demonstrate the presence of the phosphorylcholine epitope on the lipopolysaccharides (LP
71 sphorylcholine-containing secreted products (phosphorylcholine-ES) are also released by human filaria
72 coccal pce gene encoding for a teichoic acid phosphorylcholine esterase (Pce), an enzymatic activity
73 ococcal surface proteins, and the catalytic (phosphorylcholine esterase) activity is localized on the
74 ibitor 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine (ET-18-OCH3), or by using small interf
75 o be inert toward platelets, but it bound to phosphorylcholine exposed after oxidation triggered by a
76  extracts of C. elegans' microsomes transfer phosphorylcholine from L-alpha-dipalmitoyl phosphatidylc
77 o-BMA) with blood were diminished due to the phosphorylcholine functionalities of the hydrogel, which
78 search Laboratory antigen that also contains phosphorylcholine, further indicating the specificity of
79 yelectrolytes are embedded under antifouling phosphorylcholine-grafted polyelectrolytes.
80 ions, attributed to the copious zwitterionic phosphorylcholine groups for protein-adsorption resistan
81   For PEDOT functionalized with zwitterionic phosphorylcholine groups, higher levels of intermediate
82                   Our data indicate that the phosphorylcholine head group is essential for antigenici
83 id recognize lysophosphatidylcholine and the phosphorylcholine head group.
84 esence of an sn-2-oleoyl group; 2), that the phosphorylcholine headgroup independently increases mole
85 n synthesis, we successfully prepared poly(L-phosphorylcholine homoserine) with controlled chain leng
86 s lacking type IV pili, the protease, or the phosphorylcholine hydrolase are not defective for intrac
87 ., protease, acid phosphatase, p-nitrophenol phosphorylcholine hydrolase, lipase, phospholipase A, an
88 lytic enzymes metalloprotease, p-nitrophenol phosphorylcholine hydrolase, lipase, phospholipase A, an
89 pase, a phospholipase A, and a p-nitrophenyl phosphorylcholine hydrolase.
90 natural antibodies and specific tolerance to phosphorylcholine immunogens that normally recruit prote
91 ically elevated levels of diacylglycerol and phosphorylcholine in the absence of growth factors.
92 oyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphorylcholine increase interleukin-8 (IL-8) synthesi
93 d 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine induce endothelial cells to synthesize
94  1-palmitoyl-2-epoxyisoprostane-sn-glycero-3-phosphorylcholine, induce endothelial cells (EC) to synt
95  1-palmitoyl-2-epoxyisoprostane-sn-glycero-3-phosphorylcholine induced a rapid yet sustained activati
96             Soluble phosphorylserine but not phosphorylcholine inhibits substrate cleavage.
97                                              Phosphorylcholine is a common epitope in antigens of bac
98                                              Phosphorylcholine is an important bioactive adduct to th
99 factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a major primary and secondary mess
100 palmitoyl-2-epoxyisoprostane E2-sn-glycero-3-phosphorylcholine) is the most active lipid in OxPAPC th
101 lysaccharide antibody unmasked the bacterial phosphorylcholine ligand, allowing for increased adheren
102 u(25) molecular clusters functionalized with phosphorylcholine ligands (AuPC, ~2 nm in size) as a pre
103 ted primarily to the strong hydration of the phosphorylcholine-like monomers that make up the robustl
104 anied by enhanced inward movement of several phosphorylcholine lipid probes and was associated with e
105 zed a genetic locus lic that is required for phosphorylcholine metabolism in S. pneumoniae.
106 l-eluted fractions contained a huge range of phosphorylcholine-modified structures with up to three a
107 in (SM) in mammalian cells by transferring a phosphorylcholine moiety from phosphatidylcholine to cer
108  surface proteins noncovalently bound to the phosphorylcholine moiety of the cell wall of Streptococc
109 bsence of adsorbed kininogens because of its phosphorylcholine moiety.
110 modified posttranslationally at Ser(76) by a phosphorylcholine moiety.
111 ic explanation for the abnormal responses to phosphorylcholine observed in Btk-deficient mice, and in
112  (CBPs) that are non-covalently bound to the phosphorylcholine of the teichoic acid.
113 yi, strongly supporting the concept that the phosphorylcholine oligosaccharide biosynthetic enzymes a
114                 The biosynthesis in vitro of phosphorylcholine oligosaccharides in Caenorhabditis ele
115 d key components: melittin and oleyloxyethyl phosphorylcholine (OOPC).
116                           The small molecule phosphorylcholine, or choline phosphate (ChoP), is used
117 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) and its component phospholip
118 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) and its component phospholip
119 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) and, specifically, the compo
120 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) on osteogenic signaling indu
121 dized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (Ox-PAPC), activates endothelial cells
122 dized-1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (Ox-PAPC), found in atherosclerotic le
123 h as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC) and its constituents 1-palmyt
124 n of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) generates a group of bioactiv
125 es of 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC) in bronchioalveolar lavage fl
126 zed 1- palmitoyl-2-arachidonoyl-sn-3-glycero-phosphorylcholine (OxPAPC) on chemokine expression and l
127 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC), a component of minimally mod
128 ch as 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (OxPAPC), have been shown to inhibit s
129 ized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC), which has been shown to accu
130 e II-dependent exoenzymes is a p-nitrophenol phosphorylcholine (p-NPPC) hydrolase whose activity is o
131 ipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC), which then induced the stress-
132 obacillus actinomycetemcomitans, one bearing phosphorylcholine (PC) (strain D045D-40) and one devoid
133                              The zwitterions phosphorylcholine (PC) and phosphoethanolamine (PE) are
134                             Abs specific for phosphorylcholine (PC) are known to contribute to the im
135                     Antibodies reactive with phosphorylcholine (PC) are ubiquitous in human sera, but
136 ute-phase protein that binds specifically to phosphorylcholine (PC) as a component of microbial capsu
137 , specific for two determinants on R36A, the phosphorylcholine (PC) determinant of C-polysaccharide a
138 ococcal surface protein A (PspA) and for the phosphorylcholine (PC) determinant of C-polysaccharide,
139 n of the display of the virulence-associated phosphorylcholine (PC) epitope on the LOS in response to
140 oniae and house dust mite (HDM) bear similar phosphorylcholine (PC) epitopes.
141 modified (MDA-modified) LDL (MDA-LDL) or the phosphorylcholine (PC) headgroup of oxidized phospholipi
142                                              Phosphorylcholine (PC) is a classic T-independent Ag tha
143 olecular clusters (Au(25)) functionalized by phosphorylcholine (PC) ligands for NIR-II fluorescence i
144 tigators have demonstrated that HDMs express phosphorylcholine (PC) moieties.
145 e show the strong resistance of zwitterionic phosphorylcholine (PC) self-assembled monolayers (SAMs)
146 d toward oxidation-specific epitopes such as phosphorylcholine (PC) that arise during disease-driven
147 he biology of nematodes is the attachment of phosphorylcholine (PC) to carbohydrate.
148 ominated by Abs to oxidation-associated Ags, phosphorylcholine (PC), a head group that becomes expose
149                                      Because phosphorylcholine (PC), a major haptenic component of te
150          Examination of the IgG2 response to phosphorylcholine (PC), a response thought to be mainly
151         In mice, antibodies directed against phosphorylcholine (PC), an epitope present on the cell w
152 ked conjugation with a simple hapten such as phosphorylcholine (PC), induces more efficient T cell st
153 to the bacterial cell wall C-PS determinant, phosphorylcholine (PC), relative to Ig responses to the
154 ntibodies against the small-molecule epitope phosphorylcholine (PC), we show in multiple mouse models
155           Using this method, we compared the phosphorylcholine (PC)- and polycation-based binding act
156  was not associated with shifts in levels of phosphorylcholine (PC)- or pneumococcal capsular polysac
157 cture of this product was determined to be O-phosphorylcholine (PC)-AEA.
158 tans are variable with respect to display of phosphorylcholine (PC)-bearing antigens.
159       We have previously shown that ES-62, a phosphorylcholine (PC)-containing glycoprotein secreted
160 XCL13(-/-) mice are deficient in preexisting phosphorylcholine (PC)-specific antibodies and in their
161                                              Phosphorylcholine (Pc)-substituted glycans were also fou
162 ulates the production of natural Abs against phosphorylcholine (PC).
163  phenotypes by virtue of covalently attached phosphorylcholine (PC).
164 rface protein A [PspA])- and polysaccharide (phosphorylcholine [PC] determinant of teichoic acid)-spe
165 that are fully functionalized with desirable phosphorylcholine, PC, groups.
166 on period was incorporated into tissue [14C] phosphorylcholine (PCh) and [14C]phosphatidylcholine (Pt
167 odes manufacture various carbohydrate-linked phosphorylcholine (PCh)-containing molecules, including
168                                              Phosphorylcholine (PCho) is added to some LOS forms in a
169 e the result of phase-variable expression of phosphorylcholine (PCho) such that MAb 5G8 reacted only
170 ghout the biofilm, while variants expressing phosphorylcholine (PCho) were found within the biofilm.
171 ffected by phase variation was identified as phosphorylcholine (PCho), which is linked to the primary
172 f LOS glycoforms, including those containing phosphorylcholine (PCho).
173 ccharides containing sialic acid (NeuAc) and phosphorylcholine (PCho).
174  1-palmitoyl-2-epoxyisoprostane-sn-glycero-3-phosphorylcholine (PEIPC) and 1-palmitoyl-2-(5-oxovalero
175 oyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphorylcholine (PEIPC), accumulated in macrophages in
176 PC) and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine (PGPC), on Cx43 expression and phospho
177 C) and 1- palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine (PGPC), which are present in OxPAPC, M
178 phospholipids is hydrolyzed by a periplasmic phosphorylcholine phosphatase, PchP.
179 ymeric immunoglobulin receptor, or cell wall phosphorylcholine/platelet-activating factor receptor.
180 vely loaded into poly(2-methacryloyloxyethyl phosphorylcholine)-poly(2-(diisopropylamino)ethyl methac
181  antiproliferative agent, zotarolimus, and a phosphorylcholine polymer may provide similar angiograph
182 antiproliferative agent, via a biocompatible phosphorylcholine polymer on a cobalt alloy thin-strut s
183 0 or 200 microg per stent)-coated BiodivYsio phosphorylcholine polymer stents versus uncoated stents
184 rolimus-eluting coronary stents (ZES) with a phosphorylcholine polymer versus sirolimus-eluting stent
185          Compared with SES, treatment with a phosphorylcholine polymer-based ZES is associated with s
186  1-Palmitoyl-2- (5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) and 1- palmitoyl-2-glutaroyl-s
187 ives, 1-palmitoyl-2-oxovaleroyl-sn-glycero-3-phosphorylcholine (POVPC) and 1-palmitoyl-2-glutaroyl-sn
188 g 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC), are active components of mini
189 s 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC).
190                                          The phosphorylcholine product is the first to leave the acti
191  suggested that only a small fraction of the phosphorylcholine-related antibody response against T. s
192                                          The phosphorylcholine released by PlcH activity on phospholi
193 ), an enzymatic activity capable of removing phosphorylcholine residues from the cell wall teichoic a
194 on vascular endothelial cells and binding of phosphorylcholine residues on pneumococcal cell wall to
195 tein (Cbp) family are noncovalently bound to phosphorylcholine residues on the surface of Streptococc
196 the bacterial cell wall, specifically by the phosphorylcholine residues which serve as anchors for su
197                    In contrast, the IgG anti-phosphorylcholine response, although also dependent on C
198 ce, including decreased serum IgM, poor anti-phosphorylcholine responses, and slightly reduced number
199 nylcholine (1-O-hexadec-1'-enyl-sn-glycero-3-phosphorylcholine), resulting in the production of a neu
200 with radiolabeled serine, palmitic acid, and phosphorylcholine revealed that the ultraviolet B-induce
201                                 While poly(L-phosphorylcholine serine) was found to be unstable upon
202 ckness and total biomass and reduced surface phosphorylcholine, similar to a luxS mutant.
203  active Stat3, and increased reactivity with phosphorylcholine, similar to murine peritoneal B-1a and
204 ly demonstrated peritoneal B-1a cell-derived phosphorylcholine-specific and total IgM moves away from
205 d adjuvant in augmenting polysaccharide- and phosphorylcholine-specific IgG responses.
206  in protective levels of polysaccharide- and phosphorylcholine-specific IgG.
207                                   Monoclonal phosphorylcholine-specific IgG2c failed to protect rats
208  activated by TLR7 or TLR9 agonists produced phosphorylcholine-specific IgM.
209  heterogeneous with respect to its degree of phosphorylcholine substitution in both O-6-positions.
210                   Because it is thought that phosphorylcholine substitution of oligosaccharides modul
211 cal concentration of phospholipid containing phosphorylcholine, suggesting that the epitope has both
212 to the pathogen-associated molecular pattern phosphorylcholine that results in the uptake of bacteria
213 und called Lipidure (2-Methacryloyloxy ethyl phosphorylcholine) that is up to 40X less expensive than
214 rary of drug-like small molecules based upon phosphorylcholine, the active moiety of the anti-inflamm
215 e that is cross-reactive with both dsDNA and phosphorylcholine, the dominant hapten on the pneumococc
216 horylcholine, AnkX catalyzes the transfer of phosphorylcholine to Rab1 in a filamentation-induced by
217 egradation, and transfer of their headgroup, phosphorylcholine, to SMs.
218 dized 1-palmitoyl-2-arachidonyl-sn-3-glycero-phosphorylcholine), was identified in a co-regulated gro
219  of oxidized LDL, including OxPLs containing phosphorylcholine, whereas immunization with viable thym
220 rmal immune responses against Ags, including phosphorylcholine, which confer protection against Strep
221     Functional polymers with sulfobetaine or phosphorylcholine zwitterions as pendent groups are demo

 
Page Top